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        Introduction 
  Runx2, a runt domain family protein, is an essential transac-
tivator for osteoblast differentiation and bone formation. In 
Runx2-null mutant mice, both intramembraneous and endo-
chondral ossifi  cation are absent (  Komori et al., 1997  ;   Otto 
et al., 1997  ). The expression of Runx2 is a milestone for 
mesenchymal cells  ’   commitment to osteoblasts (  Ducy et al., 
1997  ;   Komori et al., 1997  ;   Otto et al., 1997  ). During the dif-
ferentiation of precursor cells into osteoblasts, Runx2 is ac-
tivated and induces osteoblast marker gene expression by 
binding to a cis-acting element, OSE2 (  Ducy et al., 1997  ). 
Several studies indicate that Runx2 is involved in the com-
mitment and differentiation of cells in the osteoblast and 
adipocyte lineages (  Chen et al., 1998  ;   Gori et al., 1999  ; 
  Lecka-Czernik et al., 1999; Enomoto et al., 2004  ;   Hong et al., 
2005  ). Multiple biological functions of Runx2 have been 
demonstrated recently (  Nam et al., 2002  ;   Taniuchi et al., 
2002  ;   Ito and Miyazono, 2003  ;   Woolf et al., 2003  ;   Aberg et al., 
2004  ;   Yoshida et al., 2004  ;   Yoshida and Komori, 2005  ;   Hinoi 
et al., 2006  ;   Pratap et al., 2006  ;   Whiteman and Farrell, 2006  ; 
  Young et al., 2007  ). 
  Runx2 is tightly regulated at both the transcriptional and 
posttranslational levels. In particular, Runx2 activity can be 
regulated through a ubiquitin  –  proteasome-mediated protein 
degradation mechanism. Smurf1 was the fi  rst factor identi-
fi  ed as an E3 ligase for Runx2 ubiquitination and degradation 
(  Zhao et al., 2003; Zhao et al., 2004  ). Smurf1-induced Runx2 
degradation can be enhanced by Smad6 (  Shen et al., 2006  ) and 
TNF (  Kaneki et al., 2006  ), as Smad6 interacts with Runx2 and 
TNF promotes the expression of Smurf1 expression in osteo-
blasts. Recently, Schnurr-3 (Shn3) was reported to recruit the 
E3 ligase WWP1 to mediate Runx2 degradation (  Jones et al., 
2006  ). The osteoblast activity is augmented in the Shn3 defi  -
ciency mice that generate adult onset osteosclerosis with in-
creased bone mass. 
  CHIP (C terminus of Hsc70-interacting protein) is a cochap-
erone protein identifi  ed through its interaction with Hsc/Hsp70 
  R
unx2, an essential transactivator for osteoblast dif-
ferentiation, is tightly regulated at both the tran-
scriptional and posttranslational levels. In this 
paper, we report that CHIP (C terminus of Hsc70-interact-
ing protein)/STUB1 regulates Runx2 protein stability via a 
ubiquitination-degradation mechanism. CHIP interacts 
with Runx2 in vitro and in vivo. In the presence of in-
creased Runx2 protein levels, CHIP expression decreases, 
whereas the expression of other E3 ligases involved in 
Runx2 degradation, such as Smurf1 or WWP1, remains 
constant or increases during osteoblast differentiation. 
Depletion of CHIP results in the stabilization of Runx2, 
enhances Runx2-mediated transcriptional activation, and 
promotes osteoblast differentiation in primary calvarial 
cells. In contrast, CHIP overexpression in preosteoblasts 
causes Runx2 degradation, inhibits osteoblast differentia-
tion, and instead enhances adipogenesis. Our data sug-
gest that negative regulation of the Runx2 protein by CHIP 
is critical in the commitment of precursor cells to differenti-
ate into the osteoblast lineage.
  CHIP promotes Runx2 degradation and negatively 
regulates osteoblast differentiation 
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  Figure 1.       Runx2 interacts with CHIP.   (A) Runx2 physically interacts with CHIP in vitro. A GST pull-down assay was performed with the puriﬁ  ed GST or GST-
CHIP protein and Myc-Runx2 protein expressed by 293T cells. (B) Interaction of Runx2 with CHIP occurs in the nucleus of mammalian cells. Cytoplasmic 
(Cy) and nuclear (Nu) extracts were used in coimmunoprecipitation assays with anti-HA antibody, and the precipitated complexes were analyzed with an 961  CHIP REGULATES R  UNX  2 ACTIVITY   • Li et al. 
anti-Myc antibody against Myc-Runx2. (C) Endogenous Runx2 and CHIP proteins interact. MC3T3-E1 cells were treated with 10   μ  M MG132 for 4 h before 
lysis. (top) Whole cell lysates were immunoprecipitated with an anti-CHIP antiserum or a preimmune serum (Pre). The immunoprecipitates were visualized 
with an anti-Runx2 antibody (65 kD*; Santa Cruz Biotechnology, Inc.). (bottom) Reversed coimmunoprecipitation assays were performed using anti-Runx2 
antibodies (MBL International) and IgG. (D) The C terminus of Runx2 interacts with CHIP. Schematic illustration of Runx2 and its truncated constructs is 
shown on top. QA, QA domain; RHD, runt homology domain; NMTS, nuclear matrix targeting signal. A GST pull-down assay was performed using the 
puriﬁ  ed GST-CHIP protein and different deletions of the hRunx2 protein expressed in mammalian cells. (E) TPR domain of CHIP is critical for the interaction 
with Runx2. Three main functional domains of CHIP (TPR, tetratricopeptide repeats; U-box, U-box domain; Charged, charged domain) are schematically 
illustrated on top. A GST pull-down assay was performed using GST-fused CHIP, and the deletion proteins to pull down the mammalian cell expressed Myc-
Runx2 protein. (F) Mutation CHIP(K31A) impairs the ability of CHIP to interact with Runx2. Lysates were prepared from 293T cells expressing HA-tagged 
CHIP, CHIP(K31A), or CHIP(H261Q) together with the indicated Myc-Runx2. Coimmunoprecipitation and immunoblotting were performed as described in A. 
The result from a longer exposure (5  ×  ) for the immunoblot is also presented (top).     
 
(  Ballinger et al., 1999  ). CHIP promotes the ubiquitination 
and degradation of chaperone-bound proteins, such as receptor 
tyrosine kinase ErbB2, glucocorticoid receptor, and the mis-
folded cystic fi   brosis transmembrane conductance regulator 
protein (  Wiederkehr et al., 2002  ). In a recent study using a 
CHIP 
   /     cell model, CHIP has been reported to elicit the tran-
scriptional activation of HSF1 during stress recovery (  Qian et al., 
2006  ). We have recently reported that CHIP regulates bone 
morphogenetic protein (BMP) and TGF-     signals by enhancing 
Smad protein ubiquitination and degradation (  Li et al., 2004  ; 
  Xin et al., 2005; Li et al., 2007  ). Here, we show that CHIP pro-
motes Runx2 ubiquitination and degradation and thereby nega-
tively regulates osteoblast differentiation. 
  Results 
  Runx2 interacts with CHIP as identiﬁ  ed 
by yeast two-hybrid and 
coimmunoprecipitation analyses in 
culture mammalian cells 
  To search for additional potential regulators of Runx2, we per-
formed a yeast two-hybrid screening experiment using the 
full-length mouse type II isoform of Runx2. CHIP was identi-
fi  ed as a Runx2-interacting protein. The interaction was con-
fi  rmed by a GST pull-down experiment (  Fig. 1 A  ). To show 
the interaction in mammalian cells, constructs expressing Myc-
Runx2 and HA-CHIP were transfected into 293T cells. Because 
CHIP is reported to mostly localize to the cytoplasm (  Ballinger 
et al., 1999  ;   Hatakeyama et al., 2001  ) and Runx2 is in the 
nucleus (  Zaidi et al., 2001  ), we determined whether the two 
proteins have any opportunity to interact in intact cells. Sepa-
ration of nuclear and cytoplasm proteins indicates that al-
though the majority of Myc-Runx2 is present in the nucleus, 
HA-CHIP is present in both the cytoplasm and the nucleus 
(Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200711044/DC1), which is consistent with a previous study 
(  Huang et al., 2004  ). Coimmunoprecipitation experiments us-
ing cytoplasmic and nuclear fractions show that Myc-Runx2 is 
precipitated by HA-CHIP protein in the nuclear extracts (  Fig. 1 B  , 
left) but not from the cytoplasmic fraction (  Fig. 1 B  , right). 
These results suggest that CHIP is capable of interacting with 
Runx2 in the nucleus of mammalian cells. Endogenous Runx2 
and CHIP protein interaction was observed in MC3T3-E1 
cells, a preosteoblast cell line (  Fig. 1 C  ). This result fi  rmly 
confi  rmed that Runx2 specifi  cally interacts with CHIP under 
physiological conditions. 
  The C terminus of Runx2 and the TPR 
domain of CHIP are critical for interaction 
  Runx2 has two protein isoforms with the glutamine  –  arginine-
rich domain (QA), DNA-binding runt homology domain, NLS, 
nuclear matrix targeting signal, and the transducin-like enhancer 
of split/groucho-interacting C-terminal pentapeptide VWRPY 
(for review see   Stein et al., 2004  ). To map the interaction do-
mains between Runx2 and CHIP proteins, we expressed the hu-
man type I isoform of Runx2 and its deletion mutants (  Zhang et al., 
2000  ) in 293T cells. The GST pull-down experiment results 
show that among the different deletions of Runx2 (  Fig. 1 D  , 
top), the full-length (hRunx2 1  –  507) and the deletion mutant 
hRunx2(88  –  507) show strong interactions with GST-CHIP 
(  Fig. 1 D  , bottom; third and fourth lanes), whereas the deletion 
mutant hRunx2(1  –  340) has completely lost, and hRunx2(1  –  424) 
only has a weak interaction with GST-CHIP. These experiments 
suggest that the C-terminal end of Runx2, which is around the 
nuclear matrix  –  targeting signal motif, contributes to the inter-
action with CHIP. As CHIP contains a tetratricopeptide repeat 
(TPR) domain responsible for chaperone binding, a U-box 
domain important for E3 ubiquitin ligase activity, and a central 
domain rich in charged residues (  Ballinger et al., 1999  ;   Murata 
et al., 2001  ), interaction with Runx2 was further mapped using 
a series of GST-CHIP deletion mutants (  Fig. 1 E  , top). The data 
show that both GST-TPR and GST  –      U-box fusion proteins in-
teract with Myc-Runx2, but GST  –  U-box and GST-    TPR do not 
(  Fig. 1 E  , bottom). This suggests that the TPR domain is neces-
sary and suffi  cient for the interaction with Runx2. 
  The chaperone activity of CHIP is required 
for its interaction with Runx2 
  Next, we investigated whether the Runx2  –  CHIP interaction is as-
sociated with the activity of CHIP. For this, we compared the inter-
action of Runx2 with the mouse CHIP(K31A) and CHIP(H261Q) 
mutants, as the K31A mutant (in the TPR domain) binds neither 
Hsp90 nor Hsp/Hsc70 chaperone (  Xu et al., 2002  ), whereas 
H261Q mutant (in the U box) fails to bind the cognate E2 and 
abolishes its E3 ligase activity (  Hatakeyama et al., 2001  ). The co-
immunoprecipitation assay results show that the interaction of 
HA-CHIP(K31A) with Myc-Runx2 is barely detectable on a short 
exposure and is still only weak with a long exposure, and HA-
CHIP(H261Q) demonstrates a strong interaction with Myc-Runx2 
(  Fig. 1 F  ). These results suggest that the interaction of CHIP with 
Runx2 is dependent on the K residue in the TPR domain, which is 
critical for the chaperone activity, as the CHIP mutation that abol-
ishes interactions with chaperones fails to interact with Runx2. JCB • VOLUME 181 • NUMBER 6 • 2008  962 
fi  fth lanes]). We speculated that CHIP might enhance Runx2 
turnover. To examine this hypothesis, Myc-Runx2 (mouse type II) 
was coexpressed with increasing amounts of HA-CHIP pro-
tein in 293T cells in the presence or absence of MG132, a pro-
teasome inhibitor. Immunoblotting results demonstrate that 
with increasing amounts of HA-CHIP, the Myc-Runx2 protein 
levels decrease in the absence of MG132 but remain constant in 
the presence of MG132 (  Fig. 2 A  ). In a parallel experiment, we 
  CHIP enhances Runx2 degradation 
and ubiquitination 
  CHIP has been reported to be an E3 ubiquitin ligase mediating 
the ubiquitination and proteasome-dependent degradation of 
several substrates (  Wiederkehr et al., 2002  ). In our experiments, 
we have observed that expression of CHIP signifi  cantly reduced 
Runx2 protein levels (Fig. S1, top; and   Fig. 1, B   [third blot] and 
F [fourth blot, compare the third lane with the fi  rst, fourth, and 
  Figure 2.       CHIP prompts Runx2 degradation and ubiquitination.   (A) CHIP mediates the degradation of Runx2 in a dose-dependent manner. Myc-Runx2 was 
coexpressed with increasing amounts of HA-CHIP in 293T cells treated with (right) or without (left) 10   μ  M MG132 for 4 h. Protein levels of Myc-Runx2 were 
measured by immunoblotting with an anti-Myc antibody. EGFP was used as a control. (B) CHIP does not induce degradation of the C-terminal truncated 
Runx2. Myc-tagged Runx2 (full length), Runx2(1  –  424), and Runx2(1  –  340) were expressed with increasing amounts of HA-CHIP in 293T cells. Levels of the 
Myc-tagged proteins were measured by immunoblotting with an anti-Myc antibody. (C and D) CHIP accelerates turnover of the Runx2 protein. A pulse-chase 
assay (C) was performed in COS7 cells transfected with Runx2 together with empty vector, CHIP, or Smurf1. Quantitative presentation of the results with 
SEM (error bars; three repeats) is shown in D. (E and F) Knocking down CHIP by siRNA increases Runx2 protein levels. pBS/U6 vector, vector-based siRNA 
targeting CHIP (CHIP RNAi), or EGFP (EGFP RNAi) was transfected with or without Myc-Runx2 vector into UMR106 cells. Myc-Runx2 (E) or endogenous 
Runx2 protein (F) levels were measured by immunoblotting with an anti-Myc antibody or an anti-Runx2 antibody (65 kD*; Santa Cruz Biotechnology, Inc.). 
(G) CHIP prompts Runx2 ubiquitination. Myc-Runx2 and His-ubiquitin (His-Ubi) were coexpressed with or without HA-CHIP in 293T cells treated with 25   μ  M 
MG132 for 4 h before lysis. Total ubiquitinated proteins were precipitated from whole cell lysates by Ni  –  nitrilotriacetic acid resin and analyzed by immuno-
blotting with an anti-Runx2 antibody. (H) Runx2 ubiquitination by CHIP occurs in the nucleus. Myc-Runx2 and His-ubiquitin were coexpressed with HA-tagged 
CHIP, CHIP(K31A), or CHIP(H261Q) in 293T cells. The nuclear exacts were separated and used for the ubiquitination experiment.     963  CHIP REGULATES R  UNX  2 ACTIVITY   • Li et al. 
gesting that CHIP is involved in Runx2 ubiquitination. In an ex-
periment with the CHIP mutants, we observed that CHIP(K31A) 
did not alter the level of Runx2 ubiquitination (  Fig. 2 H  , fourth 
lane), presumably because it fails to interact with Runx2. 
However, the expression of CHIP(H261Q) caused a decrease in 
Runx2 ubiquitination compared with wild-type CHIP (  Fig. 2 H  , 
compare the fi  fth and third lanes) but a slight increase in Runx2 
ubiquitination compared with the control vector (  Fig. 2 H  , com-
pare the fi  fth and second lanes). Because the later experiments 
were performed using nuclear proteins, the results suggest that 
CHIP enhances Runx2 ubiquitination in the nucleus. 
  CHIP decreases Runx2-induced 
transcriptional activation 
  We analyzed how CHIP infl  uences Runx2 biological activity 
using a luciferase reporter assay in which the fi  refl  y luciferase 
gene is under control of a Runx2-response element (  Zhang et al., 
2000  ). Our data demonstrate that in both NIH3T3 and COS7 
cells, the overexpression of Runx2 alone activates reporter ex-
pression four- to sixfold and that overexpression of CHIP sig-
nifi  cantly blunts the enhancing effect of Runx2 ( Fig. 3 A ). When 
the inhibitory effects of wild-type CHIP, CHIP mutants, and 
Smurf1 were compared, we observed that both of the CHIP mu-
tants could not inhibit Runx2-induced transcriptional activation 
(  Fig. 3 B  , third and fourth bar groups) but that Smurf1 had a 
similar scale of inhibitory effect as wild-type CHIP (  Fig. 3 B  , 
last bar group). CHIP(H261Q) may have a slightly enhanced 
effect on the luciferase activity (  Fig. 3 B  , fourth bar group). 
CHIP-induced attenuation of Runx2 transcriptional activity was 
also observed in the UMR106 cells ( Fig. 3 C , second bar group). 
Furthermore, when the endogenous CHIP protein was depleted 
in the UMR106 cells by CHIP siRNA (  Li et al., 2004  ;   Xin et al., 
observed that the protein levels of the two C terminus  –  truncated 
forms of Runx2, which show little or no interaction with CHIP, 
remained unchanged ( Fig. 2 B ). These results suggest that CHIP 
participates in Runx2 degradation. 
  Because Smurf1 has been reported to enhance Runx2 deg-
radation (  Zhao et al., 2003, 2004  ), we compared whether CHIP 
and Smurf1 have a similar effect on turnover rates of the Runx2 
protein. A pulse-chase analysis using COS7 cells expressing 
Myc-Runx2 alone or together with CHIP or Smurf1 show that 
overexpression of CHIP increases the Runx2 degradation rate 
( Fig. 2,  C and D [line with open squares]) compared with Smurf1 
(  Fig. 2, C and D   [line with closed triangles]). When the two E3 
ligases were coexpressed, we observed an additive effect on 
Runx2 degradation (unpublished data). These results indicate 
that CHIP is a potent factor enhancing Runx2 degradation. 
  To determine the role of CHIP on Runx2 degradation un-
der physiological conditions, we knocked down CHIP expres-
sion using siRNA in a rat osteosarcoma cell line, UMR106 
(  Fig. 2, E   [third blot, last lane] and   F   [bottom, right lane]), in 
which endogenous CHIP is moderately expressed (see Fig. 4 G). 
This results in a signifi  cant increase in the amount of either over-
expressed Myc-Runx2 protein (  Fig. 2 E  ) or endogenous Runx2 
protein (  Fig. 2 F  ). These results suggest that the endogenous 
CHIP protein degrades Runx2 in osteoblast-like cells. 
  As CHIP affects protein degradation through the ubiqui-
tination process, we examined the effect of CHIP on Runx2 
ubiquitination. We coexpressed Runx2 and polyhistidine-tagged 
ubiquitin in 293T cells with HA-CHIP. Ubiquitinated proteins 
were precipitated from cell lysates under denatured conditions 
and analyzed by immunoblotting with the anti-Runx2 antibody. 
Our results show that coexpression of CHIP is associated with a 
marked increase in the ubiquitination of Runx2 (  Fig. 2 G  ), sug-
  Figure 3.       CHIP inhibits Runx2-induced tran-
scriptional activity.   (A) Overexpression of CHIP 
inhibits Runx2-induced transcriptional activity. 
Luciferase assays were performed using 
NIH3T3 or COS7 cells transfected with the 
indicated expression vectors along with a 
Runx2-responsive reporter construct, 6xOSE2-
OC/pGL3 and pRL-TK (internal control). 
Values were normalized using the internal 
control and presented relative to basal activ-
ity (NIH3T3, ﬁ   rst bar; COS7, ﬁ   fth bar) with 
the mean from three independent repeats. 
(B) Mutants of CHIP fail to inhibit Runx2-
induced transcriptional activity. CHIP, CHIP mu-
tants, and Flag-Smurf1 were compared for the 
inhibitory effect on Runx2 activity in NIH3T3 
cells. (C) Knocking down CHIP by siRNA facili-
tates Runx2-mediated transcription in UMR106 
cells. Luciferase assays were performed in 
UMR106 cells transfected with Runx2 in the 
presence of CHIP, EGFP RNAi, or CHIP RNAi. 
(D) CHIP did not affect the transcriptional ac-
tivity of STAT3. NIH3T3 cells transfected with 
STAT3 in the presence or absence of CHIP 
along with pGL3  –  acute phase response ele-
ment and treated with 10 ng/ml interleukin-6. 
All of the data are presented as mean with SEM 
(error bars) from three independent experi-
ments. The same letter represents a signiﬁ  cant 
difference within this group in a meaningful 
comparison (P   <   0.05).     JCB • VOLUME 181 • NUMBER 6 • 2008  964 
  Figure 4.       Up-regulation of Runx2 protein level parallels reduced expression of CHIP during osteoblast differentiation.   (A) von Kossa staining for MC3T3-E1 
cells cultured for 3 wk in the presence of AA/    -GP was performed to demonstrate the cellular phenotype of osteoblasts. (B) mRNA and protein levels of Runx2 
and CHIP during the osteoblast differentiation were compared. RT-PCR and Western blot (see quantitative presentations in Fig. S2, available at http://www.jcb
.org/cgi/content/full/jcb.200711044/DC1) analyses were performed on MC3T3-E1 cells induced by AA/    -GP for the indicated number of days. (C) Smurf1 
expression is unchanged, and WWP1/Shn3 is increased during osteoblast differentiation. Real-time RT-PCR analysis was performed for the expression of the 
indicated genes during osteoblast differentiation of MC3T3-E1 cells. Values are shown relative to cells on day 0. (D) Alizarin red staining for mouse calvarial cells 965  CHIP REGULATES R  UNX  2 ACTIVITY   • Li et al. 
cultured for 2 wk in the presence of AA/    -GP. (E and F) The expression of Runx2, CHIP, WWP1, Shn3, and Smurf1 in mouse calvarial cells was analyzed as 
in B and C. (G) Real-time RT-PCR was performed to show expression of the indicated genes in different lineages of mesenchyma-originated cells. Fold induction 
was calculated based on the mRNA level of each gene in NIH3T3. (H) Expression of the CHIP (green) and Runx2 (red) proteins in osteoblasts in vivo. Double 
immunoﬂ  uorescence staining was performed using sections of trabecular (femur; a and b) and calvarial (c and d) bone from newborn mice. Enlarged osteoblasts 
(boxed) are shown on the bottom (b and d). Ob, osteoblast; Chon, chondrocyte; Fi, ﬁ  broblast-like or other types of cells. Error bars represent SEM.     
 
2005  ), we observed an increase in the luciferase activity either 
at basal (without overexpression of Runx2) or under Runx2 
overexpression (  Fig. 3 C  , last bar group). As CHIP did not af-
fect the activity of the nonrelated reporter pGL3  –  acute phase 
response element (this reporter responds to interleukin 6 through 
the activation of STAT3;   Fig. 3 D  ), these data suggest that CHIP 
decreases Runx2-induced transcriptional activation. 
  CHIP is down-regulated during 
osteoblast differentiation 
  To investigate the physiological role of CHIP on Runx2 protein 
turnover, we examined CHIP expression during osteoblast dif-
ferentiation. Treatment with ascorbic acid (AA) and    -glycero-
phosphate (  -GP) induced the differentiation of MC3T3-E1 cells 
into osteoblast-like cells, as indicated by von Kossa  –  positive 
staining (  Fig. 4 A  ) and increased AP activity examination (not 
depicted). We next analyzed CHIP and Runx2 mRNA and pro-
tein levels at different time points during early osteoblast differ-
entiation. The results show that Runx2 mRNA levels remained 
constant during 2 wk of induction ( Fig. 4 B , second blot), whereas 
both CHIP mRNA and protein levels signifi  cantly decreased over 
time (  Fig. 4 B  ). In contrast, the levels of Runx2 protein increased 
during this culture period (  Fig. 4 B  , fi  fth blot; and Fig. S2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200711044/DC1) 
concurrent with decreased CHIP protein expression. These re-
sults indicate that decreased CHIP protein levels correlate with 
increased Runx2 protein levels despite the maintenance of con-
stant Runx2 mRNA levels (obviously increased in the later stage) 
during early osteoblast differentiation. To determine the potential 
involvement of other E3 ligases, we also examined the expres-
sion of Smurf1 and WWP1 (and its adaptor Shn3), two known E3 
ligases that regulate Runx2 protein turnover, and found that the 
Smurf1 mRNA levels were unchanged and that WWP1 (also 
Shn3) mRNA levels became elevated (  Fig. 4 C  ). 
  To study the expression of the aforementioned genes in 
the later osteoblast differentiation, we isolated mouse calvarial 
cells. When these cells were cultured for further differentiation 
into mature osteoblasts (indicated by Alizarin red staining in 
 Fig. 4 D ), we observed that CHIP expression decreased, whereas 
Runx2 protein levels increased together with its mRNA levels 
(  Fig. 4, E and F  ). Changes in WWP1, Shn3, and Smurf1 mRNA 
levels remained the same as patterns observed in MC3T3-E1 
cells, the early osteoblasts. 
  Further analysis of the expression levels of Runx2, CHIP, 
WWP1, Shn3, and Smurf1 in different cell lines derived from 
mesenchymal cells was performed. We observed that Runx2 is 
not expressed in NIH3T3 (a fi  broblast cell line), C3H10T1/2 
(a pluripotent mesenchymal cell line), and C2C12 (a progenitor 
cell line for myoblasts), is moderately expressed in MC3T3-E1 
(a progenitor cell line for osteoblasts), and is abundantly 
expressed in UMR106 (an osteosarcoma cell line;   Fig. 4 G  ). 
In contrast, CHIP is expressed at high levels in C2C12, NIH3T3, 
and C3H10T1/2 cells but moderately expressed in MC3T3-E1 
and UMR106 cells ( Fig. 4 G ). Furthermore, Smurf1 is expressed 
ubiquitously in these cell lines, except it is higher in C2C12 cells. 
WWP1, similar to Shn3, is barely expressed in C2C12 cells, 
moderately expressed in NIH3T3 and C3H10T1/2 cells, and most 
highly expressed in MC3T3-E1 and UMR106 cells (  Fig. 4 G  ). 
As these cell lines represent different differentiation stages of 
mesenchymal cells, the expression patterns of these genes are 
potentially related to cell differentiation. We were particularly 
intrigued by the reversed pattern of Runx2 and CHIP expression 
in nonosteoblast (NIH3T3, C3H10T1/2, and C2C12) and osteo-
blast (MC3T3-E1 and UMR106) lineages. Collectively, these 
data suggest that CHIP is down-regulated during osteoblast dif-
ferentiation, and this down-regulation maintains Runx2 protein 
stability. The coexpression of CHIP and Runx2 in osteoblasts 
in vivo was fi  nally confi  rmed by double immunofl  uorescence 
staining using sections of calverial and trabecular bone (femur) 
from newborn mice (  Fig. 4 H   and Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200711044/DC1). 
  CHIP affects osteoblast differentiation 
and mineralization of MC3T3-E1 cells 
  To further investigate the potential functions of CHIP on osteo-
blasts, we established stable MC3T3-E1 cell lines with the over-
expression of HA-CHIP (  Fig. 5 A  ) or depletion of endogenous 
CHIP (  Fig. 5 C  , left). The stable cell lines were treated with 
AA/    -GP for different periods of time and analyzed for Runx2 
expression. AA/   -GP induced an elevation of Runx2 protein lev-
els but not mRNA levels in the mock cells (  Fig. 5 B  , left lanes), 
whereas Runx2 protein levels decreased in HA-CHIP  –  expressing 
clones (  Fig. 5 B  ). These results indicate that overexpression of 
CHIP decreases Runx2 protein levels but has no effect on its 
mRNA levels in the MC3T3-E1 cells. On the other hand, we ob-
served that CHIP depletion by siRNA in  creased Runx2 protein 
levels but did not affect its mRNA ( Fig. 5 C ). These data indicated 
the role of endogenous CHIP in the regulation of Runx2 protein. 
  To investigate whether the overexpression of CHIP affects 
the differentiation of cells into osteoblasts, we characterized the 
cells by induction with AA/    -GP for different periods of time. 
First, we observed that AP activity was dramatically decreased 
in the two HA-CHIP  –  expressing clones but signifi  cantly in-
creased in the two CHIP knockdown clones compared with the 
two mock cells (  Fig. 5 D  ). Alizarin red staining demonstrated 
similar results (  Fig. 5 E  ). Furthermore, real-time RT-PCR was 
performed to examine expression of the osteoblast differentia-
tion marker genes (bone sialoprotein [BSP] and osteocalcin 
[OCN]). Expression of these genes was delayed in the over-
expression clones or enhanced in the depletion clones ( Fig. 5 F  ), 
whereas the other E3 ligase genes known to participate in Runx2 
degradation were not affected (not depicted). These results indicate JCB • VOLUME 181 • NUMBER 6 • 2008  966 
observation that the overexpression of CHIP decreased Runx2 
protein levels, we hypothesized that CHIP may prevent precur-
sor cells from differentiating into osteoblasts but may promote 
cells to differentiate into adipocytes. When the two MC3T3-E1  –
  CHIP clones were cultured under confl  uence for long times, 
cells appeared with features of adipocytes, including the accumu-
lation of triglyceride lipid droplets (Oil Red O staining positive; 
  Fig. 6 A  , left; #2 and #8). When these cells were induced using 
the adipogenesis inducer DIM (dexamethasone, 3-isobutyl-1-
methylxanthine, and insulin) mixture, the percentages of the 
that increased CHIP overexpression prevents or delays cell dif-
ferentiation into mature osteoblasts, and the depletion of CHIP 
promotes or enhances this process. 
  Overexpression of CHIP drives MC3T3-E1 
cells to differentiate into adipocytes 
but has no effect on the adipocytic 
differentiation of C3H10T1/2 cells 
  MC3T3-E1 cells are committed to differentiate into osteoblasts 
by the expression of Runx2 (  Prince et al., 2001  ). Based on the 
  Figure 5.       Stable expression of CHIP inhibits osteoblast differentiation and mineralization.   (A) Establishment of cell lines stably expressing HA-CHIP in 
MC3T3-E1 cells (#2 and #8). Endogenous CHIP and HA-CHIP expression was measured by immunoblotting with an anti-CHIP antiserum. (B) Stable ex-
pression of HA-CHIP in MC3T3-E1 cells reduces the endogenous Runx2 protein levels. The cell lines were treated with AA/    -GP for the indicated days. 
The mRNA (top) and protein (bottom) levels of Runx2 were measured by RT-PCR and Western blotting, respectively. (C) Stable depletion of CHIP using 
siRNA in MC3T3-E1 cells increased Runx2 protein levels. The cell lines with depletion of CHIP (#9 and #20) were treated with AA/    -GP for the indicated 
days. mRNA (left) and protein (right) levels of Runx2 were measured by RT-PCR and Western blotting, respectively. (D  –  F) CHIP inhibits the differentiation of 
MC3T3-E1 cells into osteoblast-like cells. CHIP- or CHIP siRNA  –  expressing cell lines were induced to differentiate into osteoblast-like cells in the presence of 
AA/    -GP for 4  –  21 d followed by the determination of AP activity (D), calcium accumulation by Alizarin red staining (E), and expression of the osteoblast 
marker genes (BSP and OCN) by real-time RT-PCR (F). Error bars represent SEM.     967  CHIP REGULATES R  UNX  2 ACTIVITY   • Li et al. 
mediated Runx2 protein turnover, we used C3H10T1/2 cells, a 
pluripotent cell line with features of mesenchymal stem cells. 
Consistent with previous studies (for review see   Rosen and 
Spiegelman, 2000; Saito et al., 2002  ), we found that this cell line 
does not express Runx2 (  Fig. 4 G  ) and can be induced by DIM 
into adipocytes (  Fig. 6 E  , mock). We then established cell lines 
that stably overexpress HA-CHIP in C3H10T1/2 cells (  Fig. 6 D  ). 
Our data show that DIM treatment results in similar percentages 
of differentiated adipocytes in both the mock and stable cell 
lines (  Fig. 6, E and F  ), suggesting that the overexpression of 
CHIP has no effect on the commitment of C3H10T1/2 cells to 
the adipocyte lineage. The mRNA levels of PPAR     and  CEBP   
also showed no signifi   cant change between the mock and 
C3H10T1/2-CHIP cell lines after DIM treatment for 7 d (  Fig. 6 G   
and Fig. S4, c and d). These results suggest that CHIP does not 
affect adipogenesis in uncommitted mesenchymal cells (without 
Runx2 expression) and only functions in the osteoblastic cell 
lineage (with Runx2 expression). Indeed, we also observed that 
triglyceride-containing cells increased to 37.8   ±   6.7% (#2) and 
28.6   ±   4.3% (#8) compared with the noninduced 6.0   ±   1.9% (#2) 
and 3.4   ±   1.4% (#8;   Fig. 6, A and B  ). No triglyceride-containing 
cells could be detected in mock cells cultured in the absence or 
presence of DIM mixture. 
  In addition to cell morphology changes, we also examined 
the expression of the adipocyte marker genes PPAR     and 
CEBP    . Our data show that expression of these genes is dra-
matically increased after 7 d of DIM treatment in the MC3T3-E1  –
  CHIP clones (  Fig. 6 C   and Fig. S4, a and b; available at 
http://www.jcb.org/cgi/content/full/jcb.200711044/DC1). Sig-
nifi  cantly elevated PPAR     and CEBP     mRNA levels were even 
observed in the MC3T3-E1  –  CHIP cell clones without treatment 
(  Fig. 6 C   and Fig. S4, a and b). These data suggest that exoge-
nous expression of CHIP directs MC3T3-E1 cells to differenti-
ate into adipocytes. 
  To determine whether the CHIP-induced reversed differ-
entiation of preosteoblast to adipocyte is dependent on CHIP-
  Figure 6.       Overexpression of CHIP drives 
MC3T3-E1 cells to differentiate into adipocytes 
but has no effect on adipocyte differentiation 
in C3H10T1/2 cells.   (A  –  C) Overexpression of 
CHIP results in the facilitated differentiation of 
MC3T3-E1 cells into adipocytes. MC3T3-E1-
CHIP cell lines (#2 and #8) and the mock cells 
were cultured in the presence or absence of 
DIM mixture for 7 or 14 d. Accumulation of 
cytoplasmic triglyceride was detected by Oil 
Red O staining (A). A quantitative representa-
tion of positive Oil Red O staining adipocytes. 
Cell numbers were counted on three random-
ized ﬁ  elds with a phase-contrast microscope. 
The percentages of triglyceride-containing 
cells are shown with mean and SD (error 
bars; B). The overexpression of CHIP induces 
the expression of adipocyte marker genes 
PPAR     and CEBP    . RT-PCR was performed on 
day 7 (C). (D) Establishment of cell lines stably 
expressing HA-CHIP in C3H10T1/2 cells (#8 
and #11). Protein levels of the endogenous 
CHIP and HA-CHIP are shown. (E  –  G) CHIP 
does not affect the ability of C3H10T1/2 cells 
to differentiate into adipocytes. C3H10T1/
2-CHIP cell lines (#8 and #11) were used in 
adipocyte differentiation experiments. Oil Red 
O staining shows accumulation of cytoplasmic 
triglyceride on day 14 (E) with a quantitative 
representation of positive Oil Red O staining 
adipocytes (F) and expression of PPAR     and 
CEBP     on day 7 (G).     JCB • VOLUME 181 • NUMBER 6 • 2008  968 
in wild-type MC3T3-E1 cells induced by AA/   -GP,  we  ob-
served that CHIP expression decreases signifi  cantly with cell 
differentiation but that Smurf1 expression remains unchanged 
(  Fig. 4, C and F  ). Moreover, in comparison with Smurf1, which 
is ubiquitously expressed in different cell lines, CHIP expres-
sion is more restricted to preosteoblast cells (  Fig. 4  ). These ob-
servations indicate that CHIP-facilitated Runx2 degradation is 
closely related to its role in osteoblast differentiation. 
  Recently, WWP1, another Nedd4 family E3 ligase, has 
been reported to be responsible for Runx2 ubiquitination and 
degradation. WWP1 is recruited to Runx2 by an adaptor protein, 
Shn3, and mice lacking Shn3 indeed display adult onset osteo-
sclerosis with increased bone mass as a result of augmented os-
teoblast activity (  Jones et al., 2006  ). In this study, we show that 
the expression level of WWP1 is up-regulated during osteoblast 
(from both cell lines and primary cultured calvarial cells) differ-
entiation in vitro, which is consistent with a previous study 
(  Jones et al., 2006  ). Also, WWP1 is expressed at higher levels in 
the osteoblast lineages (  Fig. 4 G  , MC3T3-E1 and UMR106). 
The increased levels of WWP1/Shn3 together with the increased 
Runx2 proteins during the osteoblast differentiation are not con-
cordant with the role of WWP1/Shn3 on Runx2 protein degra-
dation. One possible explanation is that WWP1 may not play a 
role in Runx2 protein degradation at this stage of osteoblast dif-
ferentiation. Indeed, knocking out Shn3, a WWP1 adaptor, leads 
to enhanced mineralization in calvarial osteoblasts but has no 
effect on AP induction (  Jones et al., 2006  ). Because elevation of 
AP activity occurs before the formation of mineralized matrix 
nodules, it could be concluded that Shn3 and WWP1 function at 
the mineralization stage, as Runx2 has to be turned off in fully 
matured osteoblasts. In our study, we observed impaired AP in-
duction in CHIP-overexpressing MC3T3-E1 cells from an early 
stage of differentiation. Therefore, we suggest that both CHIP 
and WWP1 are responsible for the degradation of Runx2 but 
function at different stages of osteoblast differentiation. We pro-
pose that CHIP maintains the low levels of Runx2 protein in 
preosteoblasts and is turned down when differentiation starts to 
ensure that Runx2 protein can be quickly elevated to the level 
high required to initiate further osteoblast differentiation. When 
cells have fully differentiated to mature osteoblasts, WWP1 (or 
Shn3) expression is elevated to maintain the common features 
of osteoblasts. Our data depict a complex relationship among 
the different E3 ligases in regulating Runx2 protein levels dur-
ing preosteoblast differentiation. 
  It still remains to be determined whether there is an adap-
tor involved in the regulation of CHIP  –  Runx2 interaction, as in 
the case of WWP1 and Shn3. In our study, we observed that the 
H261Q mutant of CHIP causes an increase in Runx2 protein 
level (  Fig. 1 F  ). It is conceivable that CHIP(H261Q) loses its E3 
activity because it lacks the capability to bind its cognate E2 en-
zyme. In addition, the H261Q mutant was found to retain, rather 
than lose, the ability to ubiquitinate Runx2 (  Fig. 2 H  , last lane). 
Similar results were also observed on CHIP-mediated E47 deg-
radation (  Huang et al., 2004  ). On the other hand, CHN-1, the 
  Caenorhabditis elegans   orthologue of CHIP, was reported to 
form a complex with UFD-2, an enzyme known to have ubiquitin-
conjugating E4 activity in yeast, and this complex is necessary 
the overexpression of CHIP by adenovirus starts to enhance 
PPAR     and CEBP     gene expression in primary calvarial cells 
(Fig. S5, available at http://www.jcb.org/cgi/content/full/jcb
.200711044/DC1). Collectively, we propose that by degrading 
Runx2 protein, CHIP is an inhibitor for osteoblast differentiation. 
The down-regulation of CHIP expression is an important event 
to initiate osteoblast differentiation, which releases Runx2 pro-
tein to allow further progress in osteoblast differentiation. 
  CHIP functions on the primary osteoblasts 
  Finally, we address whether CHIP functions in primary osteo-
blasts. For this purpose, we generated adenovirus to overexpress 
(Ad-CHIP) or deplete (Ad-CHIPi) CHIP in isolated calvarial 
cells. After we tested the effi  cacy of the virus infection (not de-
picted), we infected calvarial cells with the adenovirus (  Fig. 7 A  ). 
Western blots demonstrated that the Runx2 protein levels were 
largely depleted in the presence of the Ad-CHIP virus but in-
creased in the presence of the Ad-CHIPi virus ( Fig. 7 B ). The Aliza-
rin red staining experiments indicated that the over  expression of 
CHIP blocked differentiation of the cells into mature osteoblasts 
but that depletion of CHIP signifi  cantly enhanced osteoblast 
maturation compared with the control virus (Ad-EGFP;   Fig. 7 C  ). 
The inhibited osteoblast differentiation by overexpression of 
CHIP with the virus was further confi  rmed by examining the ex-
pression of osteoblast-specifi  c marker genes BSP and OCN (  Fig. 
7 D  , middle bar groups). Reversely, depletion of CHIP with the 
Ad-CHIPi virus resulted in a higher level of the marker gene ex-
pression (  Fig. 7 D  , right bar groups). These data strongly indicate 
that CHIP has an inhibitory role during osteoblast differentiation. 
  Discussion 
  Runx2 is a critical transactivator in osteoblast differentiation. 
The activity of Runx2 is tightly regulated at different levels, 
including transcription (  Sudhakar et al., 2001a  ), translation 
(  Sudhakar et al., 2001b  ), phosphorylation (  Kim et al., 2006  ; 
  Rajgopal et al., 2006  ), acetylation (  Jeon et al., 2006  ), protein  –
  protein interactions (  Hong et al., 2005; Dobreva et al., 2006  ), 
and ubiquitin-mediated degradation (  Zhao et al., 2003; Jones 
et al., 2006  ). The important role of the posttranslational regula-
tion of Runx2 has been demonstrated by experiments showing 
that dexamethasone treatment yields a signifi  cant increase in 
Runx2 protein levels without affecting its mRNA expression 
( Prince  et  al.,  2001  ). In this study, we show that CHIP is a novel 
posttranslational regulator of Runx2 through several lines of 
evidence. Our fi  ndings suggest that CHIP has an important role 
in the regulation of Runx2 protein levels and cell commitment 
in osteoblast precursor cells. 
  Previously, several other E3 ligases have been reported to 
regulate Runx2 protein turnover, including Smurf1, a HECT 
domain E3 ubiquitin ligase. Smurf1 has been reported to di-
rectly interact with Runx2 and to induce ubiquitin-dependent 
degradation of Runx2 protein (  Zhao et al., 2003  ). In this study, 
we compared the infl  uences of Smurf1 and CHIP in mediating 
Runx2 degradation. We found that both overexpressed CHIP 
and Smurf1 mediate Runx2 degradation (  Fig. 2, C and D  ) and 
thus inhibit Runx2-mediated transcription (  Fig. 3 B  ). However, 969  CHIP REGULATES R  UNX  2 ACTIVITY   • Li et al. 
C2C12 cells. These observations implicate that the regulation of 
CHIP gene expression together with that of WWP1 and Smurf1 
yields a specifi  c pattern for different fates of the cells and may 
be controlled by common factors during cell differentiation. 
  We have reported that CHIP facilitates the degradation of 
Smad proteins in several cell lines (  Li et al., 2004  ;   Xin et al., 
2005  ). Because Smad proteins are critical mediators of BMP/
TGF-     signals, which play important roles in osteoblast differ-
entiation, and activation of BMP signaling has been reported to 
activate Runx2 mRNA expression (  Ito and Miyazono, 2003  ), 
we questioned whether CHIP overexpression would also block 
these signals in osteoblasts. In our experiments, we adopted 
and sufficient to multiubiquitylate UNC-45 in vitro (  Hoppe 
et al., 2004  ). We presume that other factors such as the Hsc70  –
  Skp2 complex might also be involved in the Runx2 ubiquitina-
tion process mediated by CHIP. 
  It is not clear how CHIP expression is regulated at the 
transcriptional level during osteoblast differentiation. Our data 
indicate that CHIP is down-regulated when cells differentiate 
into osteoblasts and is maintained at high levels in nonosteoblast 
lineages. Conversely, WWP1 (also Shn3) is up-regulated when 
cells differentiate into osteoblasts but is maintained at a basal 
level at the early stage of differentiation (in uninduced MC3T3-E1, 
NIH3T3, or C3H10T1/2 cells) or is completely turned off in 
  Figure 7.       CHIP inhibits osteoblast differentiation.   (A) Microscopic analysis of GFP expression 4 d after adenoviral infection shows equally efﬁ  cient trans-
duction (up to 70%) of primary mouse calvarial cells. GFP is expressed from the same viral vector as CHIP or CHIP siRNA. (B) Examination of the adenovirus 
expressing CHIP (Ad-CHIP) or CHIP siRNA (Ad-CHIPi) on endogenous Runx2 protein levels in calvarial cells. GFP levels indicate amounts of virus infection. 
(C) Alizarin red staining of mouse calvarial osteoblasts transfected with the adenovirus expressing GFP, CHIP, or CHIP siRNA and cultured in the presence 
of AA/    -GP for 2 wk. (D) Real-time RT-PCR demonstrates that the mRNA of bone marker genes (BSP and OCN) in the mouse primary calvarial cells infected 
the virus in the condition of osteoblast differentiation. Error bars represent SEM. (E) A schematic presentation of the functions of CHIP on osteoblast dif-
ferentiation. Although Runx2 mRNA is expressed in preosteoblast cells, the Runx2 protein level remains at a low level because high CHIP expression leads 
to its degradation. When cells commit to differentiate into osteoblasts, CHIP expression decreases, leading to increased Runx2 protein levels, which drives 
the cells to become mature osteoblasts. WWP1 seems to enhance Runx2 degradation in the late stage of osteoblast differentiation (  Jones et al., 2006  ). 
The question mark indicates an undeﬁ  ned stage of the function. This diagram has been modiﬁ  ed from   Komori, 2005  .     JCB • VOLUME 181 • NUMBER 6 • 2008  970 
  HEK293T, COS7, and C2C12 cells were cultured in DME supple-
mented with 10% FBS. NIH3T3 cells were maintained in DME supple-
mented with 10% newborn calf serum, which was replaced with 10% FBS 
the day before transfection. MC3T3-E1 and UMR106 cells were cultured in 
    MEM supplemented with 10% FBS. C3H10T1/2 cells were cultured in 
basal medium Eagle supplemented with 10% FBS. All of the cells were kept 
at 37  °  C in a 5% CO  2  -containing atmosphere. The stable cell lines were se-
lected by 1 mg/ml G418 (Sigma-Aldrich) after transfection of the related 
plasmids, and the obtained clones were maintained in media containing 
400   μ  g/ml G418. 
  In the induction of osteoblast differentiation, cells were treated with 
AA/    -GP (50   μ  g/ml AA and 10 mM     -GP for primary mouse calvarial 
osteoblastic cells using 5 mM     -GP) for the indicated days. In the adipo-
genesis experiments, cells were cultured in the presence of DIM (1   μ  M 
dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, and 1   μ  g/ml insulin) 
for up to 14 d. Media were changed every 3 d. 
  Protein assays and luciferase assay 
  Protein extraction, immunoblotting, coimmunoprecipitation, ubiquitination, 
GST pull down, pulse-chase assays, and luciferase assay were performed 
according to previous studies (  Li et al., 2004  ;   Xin et al., 2005  ). 
  Reverse transcription/real-time PCR 
  DNase-treated RNA was reverse transcribed with SuperScript II reverse 
transcription (Invitrogen) using random hexamer primer (Promega). The re-
sulting cDNA was subsequently used for PCR or quantitative real-time PCR 
analyses. Primer sequences are listed in Table S1 (available at http://
www.jcb.org/cgi/content/full/jcb.200711044/DC1). 
  AP activity assay 
  Cells were plated at a density of 10 
4   cells/cm 
2   for osteoblast differentiation. 
Cultures from indicated days were lysed with 250   μ  l of 0.1% Triton X-100/
well. 500   μ  l of freshly prepared 20-mM   p  -nitrophenyl-phosphate in AMP buf-
fer (1.5 M AMP and 0.1 M MgCl  2  , pH 10.3) was mixed with 100   μ  l of cell 
lysate and incubated for 30 min at 37  °  C until the reaction was terminated 
with 2 ml of 0.25-M NaOH solution. The product   p  -nitrophenol had a colori-
metric determination at 405 nm (  Coelho and Fernandes, 2000  ). Protein con-
centration of the lysate was determined using the BCA protein assay kit 
(Thermo Fisher Scientiﬁ  c). AP activity was standardized as OD405/OD562. 
The experiment was repeated three times, and SEM was calculated. 
  Histochemical assays 
  Cultures were ﬁ  xed with 95% ethanol for 10 min and rinsed with distilled 
water. Phosphate deposits were assessed by von Kossa staining. The ﬁ  xed 
cultures were covered with a 1.0% AgNO  3   solution and kept for 1 h under 
UV light. After rinsing, a 5.0% NaS  2  O  3   solution was added for 2 min, and 
cultures were washed again. For calcium staining, the ﬁ  xed cultures were 
covered with a 1.0% Alizarin red solution (0.028% NH  4  OH, pH 6.4) for 
2 min and rinsed with distilled water and acid ethanol (ethanol and 0.01% 
HCl). Lipid droplets were examined with Oil Red O staining, and the posi-
tive cells were counted with a microscope (BX-51; Olympus) and CCD 
camera (DP70; Olympus). 
  Immunoﬂ  uorescence staining 
  The bones were ﬁ  xed in 10% formalin and embedded with parafﬁ  n. Sec-
tions were incubated with anti-CHIP and anti-Runx2 antibodies overnight at 
4  °  C followed by FITC- and TRITC-labeled second antibodies for 60 min at RT. 
Nuclei were labeled with DAPI nuclear dye (blue). Sections were mounted 
with glycerol and photographed with a microscope (Eclipse C1si; Nikon). 
  Preparation of primary mouse calvarial osteoblastic cells 
  Calvariae from newborn mice were dissected aseptically and treated with 
0.2% collagenase (Sigma-Aldrich) for 20 min with shaking. Cell suspen-
sion in collagenase was collected and transferred into a 50-ml tube by 
adding FBS to 10% (to inactive collagenase). Then, fresh collagenase was 
added with shaking for second digestion. Digestion was repeated six times 
to obtain as many cells as possible (the cells from the ﬁ  rst digestion were 
discarded). Cells were plated at a density of 1.5   ×   10 
4   cells/cm 
2   and cul-
tured in     MEM supplemented with 10% FBS to conﬂ  uent. 
  Adenoviral infection of calvarial osteoblasts 
  Calvarial cells were transduced with adenoviruses expressing GFP, CHIP, 
or CHIP siRNA or the empty virus (pAdTrack-cytomegalovirus). Virus parti-
cles were administered at 50 plaque-forming units/cell in     -MEM with 
1% FBS and incubated for 1 h at 37  °  C. After 1 h, medium was aspirated, 
AA/    -GP (rather than BMP2) to induce MC3T3-E1 and calvar-
ial cell differentiation. Our observations on the cell differentiation 
affected by CHIP suggest that AA/    -GP induces cell differenti-
ation through a pathway not directly related to BMP signaling. 
Whether CHIP plays a role in BMP signaling to regulate osteo-
blast differentiation in vivo remains to be studied. 
  The biological signifi  cance of CHIP-mediated Runx2 reg-
ulation on preosteoblast differentiation is underscored by its de-
pendence on preosteoblast-specifi  c cell types. In contrast to the 
MC3T3-E1 cells, which express Runx2 and are committed to 
the osteoblast lineage, overexpression of CHIP in C3H10T1/2 
cells that are defi  cient in Runx2 expression did not change the 
differentiation potential (to become adipocytes) of these cells. 
Based on these and previous work (  Komori, 2005  ) on Runx2, 
we propose a model by which CHIP interacts with Runx2 and 
regulates preosteoblast differentiation (  Fig. 7 E  ). In this model, 
CHIP regulates Runx2 protein levels and thereafter regulates the 
commitment of preosteoblast differentiation to osteoblasts and 
adipocytes. CHIP levels decrease steadily during preosteoblast 
differentiation accompanied by a steady increase in Runx2 pro-
tein levels. This model can explain our observations that the 
forced expression of CHIP prevented the committed differen-
tiation of preosteoblasts to osteoblasts, resulting in adipocyte 
differentiation. This is consistent with previous studies on the 
effect of Runx2 on adipocyte differentiation, as Runx2 has been 
shown to be an inhibitor that prevents mesenchymal cells from 
entering into the adipocyte lineage (  Lecka-Czernik et al., 1999; 
Kobayashi et al., 2000  ;   Jeon et al., 2003  ), and Runx2 defi  ciency 
in chondrocytes stimulates their differentiation to adipocytes 
(  Enomoto et al., 2004  ). Collectively, our data identifi  es for the 
fi  rst time an important role of CHIP in regulating preosteoblast 
differentiation by modulating the protein levels of Runx2 
through ubiquitination and protein degradation. This enriches 
our knowledge of the regulation of Runx2 protein during the os-
teoblast differentiation in addition to the known negative regu-
lators WWP1/Shn3 and Smurf1/2. 
  Materials and methods 
  Antibodies 
  The antiserum against CHIP was generated by immunizing rabbits with 
puriﬁ  ed GST-CHIP(1  –  161) in this laboratory. Anti  –      -actin and anti-Runx2 
(8G5) were purchased from Sigma-Aldrich and MBL International, respec-
tively. Other antibodies (including anti-PEBP    A and M70) were purchased 
from Santa Cruz Biotechnology, Inc. 
  Plasmids, cell lines, and cultures 
  Type II mouse Runx2 cDNA was cloned from pBSA3 (provided by G. 
Karsenty, Columbia University, New York, NY;   Ducy et al., 1997  ) and in-
serted into the pGBKT7 and pCMV/Myc vectors (Clontech Laboratories, 
Inc.). Constructs expressing deletions of type I human Runx2 (PEBP2    A) were 
provided by Y. Ito (Institute of Molecular and Cell Biology, Singapore;   Zhang 
et al., 2000  ). pGL3/6xOSE2-OC-luc was described previously (  Zhao et al., 
2003  ). pGEX-5X-3/CHIP and its deletions, pcDNA6/HA-CHIP, pcDNA6/
HA-CHIP(K30A), pcDNA6/HA-CHIP(H260Q), and pACT-2/CHIP, together 
with CHIPi constructs were preserved in our laboratory (  Li et al., 2004  ;   Xin 
et al., 2005  ). The siRNA target sequences for mouse CHIP is 5    -AACAG-
GCACTTGCTGACTG-3     and for human CHIP is 5    -AGCAGGCCCTGGC-
CGACTG-3    . His-ubiquitin and Flag-Smurf1 were provided by Y. Chen 
(Tsinghua University, Beijing, China). pEFNue/HA-CHIP was generated from 
pcDNA6/HA-CHIP. The recombinant adenoviruses expressing GFP, CHIP-
GFP, and CHIPi-GFP were constructed using the pAd Easy system. 971  CHIP REGULATES R  UNX  2 ACTIVITY   • Li et al. 
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